Human genetic and immunological determinants of critical COVID-19 pneumonia
SARS-CoV-2 infection is benign in most individuals but, in around 10% of cases, it triggers
hypoxaemic COVID-19 pneumonia, which leads to critical illness in around 3% of cases …
hypoxaemic COVID-19 pneumonia, which leads to critical illness in around 3% of cases …
Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis
Background Data on the association of human immunodeficiency virus (HIV) infection with
adverse outcomes in patients with COVID-19 are conflicting. This systematic review and …
adverse outcomes in patients with COVID-19 are conflicting. This systematic review and …
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society–USA panel
Importance Recent advances in treatment and prevention of HIV warrant updated
recommendations to guide optimal practice. Objective Based on a critical evaluation of new …
recommendations to guide optimal practice. Objective Based on a critical evaluation of new …
Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data
Background Evidence of whether people living with HIV are at elevated risk of adverse
COVID-19 outcomes is inconclusive. We aimed to investigate this association using the …
COVID-19 outcomes is inconclusive. We aimed to investigate this association using the …
Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical …
Background WHO has established a Global Clinical Platform for the clinical characterisation
of COVID-19 among hospitalised individuals. We assessed whether people living with HIV …
of COVID-19 among hospitalised individuals. We assessed whether people living with HIV …
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a …
Background Factors affecting outcomes of SARS-CoV-2 infection in people living with HIV
are unclear. We assessed the factors associated with SARS-CoV-2 diagnosis and severe …
are unclear. We assessed the factors associated with SARS-CoV-2 diagnosis and severe …
Major revision version 11.0 of the European AIDS clinical society guidelines 2021
Abstract Background The European AIDS Clinical Society (EACS) Guidelines were revised
in 2021 for the 17th time with updates on all aspects of HIV care. Key points of the …
in 2021 for the 17th time with updates on all aspects of HIV care. Key points of the …
Persistent SARS-CoV-2 infection and intra-host evolution in association with advanced HIV infection
While most people effectively clear SARS-CoV-2, there are several reports of prolonged
infection in immunosuppressed individuals. Here we present a case of prolonged infection …
infection in immunosuppressed individuals. Here we present a case of prolonged infection …
Bifurcation and optimal control analysis of HIV/AIDS and COVID-19 co-infection model with numerical simulation
HIV/AIDS and COVID-19 co-infection is a common global health and socio-economic
problem. In this paper, a mathematical model for the transmission dynamics of HIV/AIDS and …
problem. In this paper, a mathematical model for the transmission dynamics of HIV/AIDS and …
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study
LC Netto, KY Ibrahim, CM Picone, APPS Alves… - The Lancet …, 2022 - thelancet.com
Background People living with HIV might have a poor or delayed response to vaccines,
mainly when CD4 cell counts are low, and data concerning COVID-19 vaccines in this …
mainly when CD4 cell counts are low, and data concerning COVID-19 vaccines in this …